本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.13
+0.08508.17%
盘后1.130.00000.00%18:13 EDT
成交量:5.75万
成交额:6.22万
市值:1,445.97万
市盈率:-1.04
高:1.13
开:1.07
低:1.05
收:1.04
数据加载中...
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/03

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/02/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

招股说明书

Registration statement for certain foreign private issuers
2020/01/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]